Department of Neurology, Duke University Hospital (S. Shah, Y.X.), Durham, NC.
Duke Clinical Research Institute (S. Shah, Y.X., S. Sheng), Durham, NC.
Circulation. 2019 Mar 26;139(13):1568-1577. doi: 10.1161/CIRCULATIONAHA.118.036509.
The use of endovascular therapy (EVT) in patients with acute ischemic stroke who have large vessel occlusion has rapidly increased in the United States following pivotal trials demonstrating its benefit. Information about the contribution of interhospital transfer in improving access to EVT will help organize regional systems of stroke care.
We analyzed trends of transfer-in EVT from a cohort of 1 863 693 patients with ischemic stroke admitted to 2143 Get With The Guidelines-Stroke participating hospitals between January 2012 and December 2017. We further examined the association between arrival mode and in-hospital outcomes by using multivariable logistic regression models.
Of the 37 260 patients who received EVT at 639 hospitals during the study period, 42.9% (15 975) arrived at the EVT-providing hospital after interhospital transfer. Transfer-in EVT cases increased from 256 in the first quarter 2012 to 1422 in the fourth quarter 2017, with sharply accelerated increases following the fourth quarter 2014 ( P<0.001 for change in linear trend). Transfer-in patients were younger and more likely to be of white race, to arrive during off-hours, and to be treated at comprehensive stroke centers. Transfer-in patients had significantly longer last-known-well-to-EVT initiation time (median, 289 minutes versus 213 minutes; absolute standardized difference, 67.33) but were more likely to have door-to-EVT initiation time of ≤90 minutes (65.6% versus 23.6%; absolute standardized difference, 93.18). In-hospital outcomes were worse for transfer-in patients undergoing EVT in unadjusted and in risk-adjusted models. Although the difference in in-hospital mortality disappeared after adjusting for delay in EVT initiation (14.7% versus 13.4%; adjusted odds ratio, 1.01; 95% CI, 0.92-1.11), transfer-in patients were still more likely to develop symptomatic intracranial hemorrhage (7.0% versus 5.7%; adjusted odds ratio, 1.15; 95% CI, 1.02-1.29) and less likely to have either independent ambulation at discharge (33.1% versus 37.1%; adjusted odds ratio, 0.87; 95% CI, 0.80-0.95) or to be discharged to home (24.3% versus 29.1%; adjusted odds ratio, 0.82; 95% CI, 0.76-0.88).
Interhospital transfer for EVT is increasingly common and is associated with a significant delay in EVT initiation highlighting the need to develop more efficient stroke systems of care. Further evaluation to identify factors that impact EVT outcomes for transfer-in patients is warranted.
在美国,几项关键试验证明血管内治疗(EVT)对大血管闭塞的急性缺血性脑卒中患者有益,自此,接受 EVT 的患者数量迅速增加。了解在提高 EVT 可及性方面,医院间转运的贡献,将有助于组织区域性卒中护理系统。
我们分析了 2012 年 1 月至 2017 年 12 月期间在 2143 家参与 Get With The Guidelines-Stroke 项目的医院中,1863693 例缺血性脑卒中患者的转运至 EVT 治疗的趋势。我们进一步使用多变量逻辑回归模型,分析了入院模式与院内结局之间的关联。
在研究期间,639 家医院中有 37260 例患者接受了 EVT,其中 42.9%(15975 例)在接受 EVT 前经历了医院间转运。2012 年第一季度 EVT 转运病例为 256 例,2017 年第四季度增至 1422 例,2014 年第四季度后急剧加速(线性趋势变化的 P<0.001)。转运患者更年轻,更可能为白种人,在非工作时间到达,在综合性卒中中心接受治疗。与直接至 EVT 提供医院接受治疗的患者相比,转运患者的最后已知健康时间至 EVT 开始时间明显延长(中位数 289 分钟与 213 分钟;绝对标准化差异 67.33),但更有可能在 90 分钟内接受 EVT 治疗(65.6%与 23.6%;绝对标准化差异 93.18)。未校正和校正风险后的 EVT 模型中,转运患者的院内结局较差。尽管调整 EVT 启动延迟后,院内死亡率差异消失(14.7%与 13.4%;校正优势比 1.01;95%CI 0.92-1.11),但转运患者仍更易发生症状性颅内出血(7.0%与 5.7%;校正优势比 1.15;95%CI 1.02-1.29),出院时独立活动的可能性更低(33.1%与 37.1%;校正优势比 0.87;95%CI 0.80-0.95),出院回家的可能性更低(24.3%与 29.1%;校正优势比 0.82;95%CI 0.76-0.88)。
EVT 的医院间转运越来越常见,且与 EVT 启动的显著延迟相关,这突显了开发更高效的卒中护理系统的必要性。需要进一步评估以确定影响转运患者 EVT 结局的因素。